Thermo Fisher (TMO) Director Dion J. Weisler Receives Award

What Happened
Dion J. Weisler, a director of Thermo Fisher Scientific (TMO), was credited with 55.56 deferred stock units as an award under the company's Deferred Compensation Plan for Directors on September 26, 2026. The units were valued at $675.00 each, representing a total value of approximately $37,503. These are derivative units convertible into common stock on a 1-for-1 basis and are distributable as shares upon cessation of director service or a change of control. This transaction is an award (code A), part of routine director compensation rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-26; Filing date: 2026-09-29.
• Award: 55.56 deferred stock units at $675.00 per unit; total value ≈ $37,503.
• Derivative detail: Units convertible into common stock on a 1-for-1 basis (Footnote F1).
• Plan detail: Units credited under the Issuer's Deferred Compensation Plan for Directors; retainers are deferred quarterly and become distributable as stock upon leaving the board or a change of control (Footnote F2).
• Shares owned after transaction: Not specified in the Form 4 filing.
• Timeliness: Filing reports the 9/26/2026 credit and was submitted 9/29/2026; the form does not indicate any special late-filing notation.

Context
These deferred stock units are routine director compensation and do not reflect an open-market buy or sell. They are a non-cash award that will convert to actual shares in the future under the plan's distribution conditions (cessation of service or change of control). As such, this transaction is informational about compensation, not a direct insider bet for immediate market exposure.